Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01894542
Other study ID # 2011/572-14
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date August 2013
Est. completion date December 2019

Study information

Verified date March 2022
Source University of Bergen
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The investigators have previously shown the intact protein from cod filet improves glucose regulation and serum lipid profile in overweight adults. A large amount of trimmings from various fish species such as cod is thrown away or sold at very low prices for animal feed, and analyses of the amino acid composition reveals that this can be a good protein source for humans. Two fractions are normally isolated from intact fish meal, i.e. water soluble and non-water soluble proteins. In the present study the investigators will compare these fractions, by studying their effects on glucose regulation in overweight/obese adults.


Description:

Participants receive 6g per day of water soluble on non-water soluble cod protein as tablets for 8 weeks.


Recruitment information / eligibility

Status Completed
Enrollment 55
Est. completion date December 2019
Est. primary completion date December 2014
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 20 Years to 65 Years
Eligibility Inclusion Criteria: - BMI>28 - healthy - fasting blood glucose <7.0 mmol/L - stable body weight with less than 5 kg fluctuation during the last 4 months Exclusion Criteria: - known disease or metabolic disturbances related to overweight or obesity - use of prescription medications that affect blood glucose, blood lipids or inflammatory status - allergies towards fish or seafood - undertaking a weight loss diet - tobacco use exceeding >15 cigarettes/day - pregnancy or breastfeeding - high seafood consumption - use of dietary supplements including cod liver oil or other marine fatty acids - allergies towards fish, milk, egg

Study Design


Related Conditions & MeSH terms


Intervention

Dietary Supplement:
Cod protein from presscake
6g protein per day for 8wk
Cod protein from presscake + stickwater
6 g protein per day for 8 wk
Control


Locations

Country Name City State
Norway University of Bergen Bergen

Sponsors (4)

Lead Sponsor Collaborator
University of Bergen Granit AS Transport & Tourism, Nofima, Norwegian Seafood Center

Country where clinical trial is conducted

Norway, 

References & Publications (1)

Vikøren LA, Nygård OK, Lied E, Rostrup E, Gudbrandsen OA. A randomised study on the effects of fish protein supplement on glucose tolerance, lipids and body composition in overweight adults. Br J Nutr. 2013 Feb 28;109(4):648-57. doi: 10.1017/S0007114512001717. Epub 2012 May 31. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Glucose tolerance Serum glucose will be measured in fasting and postprandial state 8 weeks
Secondary Gene expression Changes in gene expression in adipose tissue related to the circulating markers of glucose regulation. 8 weeks
Secondary Amino acids and amino acid metabolites Amino acids and amino acid metabolites will be measured in serum and urine 8 weeks
Secondary Comparisons of metabolites and co-factors involved in one-carbon metabolism in serum and urine Concentrations of relevant metabolites and co-factors were measured in serum and urine 8 weeks
See also
  Status Clinical Trial Phase
Recruiting NCT04243317 - Feasibility of a Sleep Improvement Intervention for Weight Loss and Its Maintenance in Sleep Impaired Obese Adults N/A
Recruiting NCT04101669 - EndoBarrier System Pivotal Trial(Rev E v2) N/A
Terminated NCT03772886 - Reducing Cesarean Delivery Rate in Obese Patients Using the Peanut Ball N/A
Completed NCT03640442 - Modified Ramped Position for Intubation of Obese Females. N/A
Completed NCT04506996 - Monday-Focused Tailored Rapid Interactive Mobile Messaging for Weight Management 2 N/A
Recruiting NCT06019832 - Analysis of Stem and Non-Stem Tibial Component N/A
Active, not recruiting NCT05891834 - Study of INV-202 in Patients With Obesity and Metabolic Syndrome Phase 2
Active, not recruiting NCT05275959 - Beijing (Peking)---Myopia and Obesity Comorbidity Intervention (BMOCI) N/A
Recruiting NCT04575194 - Study of the Cardiometabolic Effects of Obesity Pharmacotherapy Phase 4
Completed NCT04513769 - Nutritious Eating With Soul at Rare Variety Cafe N/A
Withdrawn NCT03042897 - Exercise and Diet Intervention in Promoting Weight Loss in Obese Patients With Stage I Endometrial Cancer N/A
Completed NCT03644524 - Heat Therapy and Cardiometabolic Health in Obese Women N/A
Recruiting NCT05917873 - Metabolic Effects of Four-week Lactate-ketone Ester Supplementation N/A
Active, not recruiting NCT04353258 - Research Intervention to Support Healthy Eating and Exercise N/A
Completed NCT04507867 - Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III N/A
Recruiting NCT03227575 - Effects of Brisk Walking and Regular Intensity Exercise Interventions on Glycemic Control N/A
Completed NCT01870947 - Assisted Exercise in Obese Endometrial Cancer Patients N/A
Recruiting NCT05972564 - The Effect of SGLT2 Inhibition on Adipose Inflammation and Endothelial Function Phase 1/Phase 2
Recruiting NCT06007404 - Understanding Metabolism and Inflammation Risks for Diabetes in Adolescents
Recruiting NCT05371496 - Cardiac and Metabolic Effects of Semaglutide in Heart Failure With Preserved Ejection Fraction Phase 2